- Home
- FDMT vs NLOP Comparison
FDMT vs NLOP Comparison
Compare FDMT & NLOP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FDMT
- NLOP
- Stock Information
- Founded
- FDMT 2013
- NLOP 2022
- Country
- FDMT United States
- NLOP United States
- Employees
- FDMT N/A
- NLOP N/A
- Industry
- FDMT Biotechnology: Pharmaceutical Preparations
- NLOP
- Sector
- FDMT Health Care
- NLOP
- Exchange
- FDMT Nasdaq
- NLOP Nasdaq
- Market Cap
- FDMT 420.7M
- NLOP 481.5M
- IPO Year
- FDMT 2020
- NLOP N/A
- Fundamental
- Price
- FDMT $6.31
- NLOP $30.91
- Analyst Decision
- FDMT Buy
- NLOP Strong Buy
- Analyst Count
- FDMT 11
- NLOP 1
- Target Price
- FDMT $42.80
- NLOP $46.00
- AVG Volume (30 Days)
- FDMT 1.0M
- NLOP 64.9K
- Earning Date
- FDMT 11-13-2024
- NLOP 01-01-0001
- Dividend Yield
- FDMT N/A
- NLOP 1.11%
- EPS Growth
- FDMT N/A
- NLOP N/A
- EPS
- FDMT N/A
- NLOP N/A
- Revenue
- FDMT $17,000.00
- NLOP $160,911,000.00
- Revenue This Year
- FDMT N/A
- NLOP N/A
- Revenue Next Year
- FDMT $87.55
- NLOP N/A
- P/E Ratio
- FDMT N/A
- NLOP N/A
- Revenue Growth
- FDMT N/A
- NLOP N/A
- 52 Week Low
- FDMT $5.58
- NLOP $16.72
- 52 Week High
- FDMT $36.25
- NLOP $33.06
- Technical
- Relative Strength Index (RSI)
- FDMT 36.69
- NLOP 43.36
- Support Level
- FDMT $5.58
- NLOP $30.63
- Resistance Level
- FDMT $7.58
- NLOP $32.93
- Average True Range (ATR)
- FDMT 0.46
- NLOP 0.85
- MACD
- FDMT -0.06
- NLOP -0.19
- Stochastic Oscillator
- FDMT 34.93
- NLOP 11.52
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.
About NLOP Net Lease Office Properties of Beneficial Interest
Net Lease Office Properties is a real estate investment trust. Through its subsidiaries it owns, operates, and finances office buildings. Its properties are primarily leased to corporate tenants on a single-tenant, net-lease basis. Its portfolio includes approximately 1.5 million square feet of Green-Certified Buildings, 4 LEED-Certified Buildings, and 1 BREEAM-Certified Building.